Royal Bank of Canada
ASMB icon

Royal Bank of Canada’s Assembly Biosciences ASMB Stock Holding History

Royal Bank of Canada’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$0 Buy
+16
New +$456 ﹤0.01% 7086
2025
Q3 		– Sell
-53
Closed -$1K – 7108
2025
Q2 		$1K Buy
+53
New +$699 ﹤0.01% 6849
2024
Q2 		– Sell
-79
Closed -$1K – 7017
2024
Q1 		$1K Buy
79
+33
+72% +$385 ﹤0.01% 6750
2023
Q4 		$0 Buy
+46
New +$437 ﹤0.01% 7084
2023
Q3 		– Sell
-28
Closed – – 7057
2023
Q2 		$0 Buy
+28
New +$344 ﹤0.01% 7225
2022
Q4 		– Sell
-16
Closed – – 7201
2022
Q3 		$0 Buy
+16
New +$387 ﹤0.01% 7422
2022
Q1 		– Sell
-2
Closed – – 7717
2021
Q4 		$0 Buy
+2
New +$66 ﹤0.01% 7636
2021
Q3 		– Sell
-860
Closed -$40K – 7611
2021
Q2 		$40K Buy
860
+559
+186% +$27.7K ﹤0.01% 6179
2021
Q1 		$16K Buy
301
+143
+91% +$9.48K ﹤0.01% 6552
2020
Q4 		$12K Buy
158
+133
+532% +$15.6K ﹤0.01% 6290
2020
Q3 		$5K Sell
25
-85
-77% -$21.4K ﹤0.01% 6124
2020
Q2 		$31K Buy
110
+73
+197% +$17K ﹤0.01% 5412
2020
Q1 		$7K Sell
37
-88
-70% -$18.9K ﹤0.01% 5927
2019
Q4 		$30K Buy
125
+100
+400% +$18.4K ﹤0.01% 5679
2019
Q3 		$3K Sell
25
-1
-4% -$151 ﹤0.01% 6175
2019
Q2 		$4K Buy
26
+1
+4% +$190 ﹤0.01% 6372
2019
Q1 		$6K Hold
25
– – ﹤0.01% 6180
2018
Q4 		$7K Sell
25
-28
-53% -$8.1K ﹤0.01% 6020
2018
Q3 		$23K Buy
53
+28
+112% +$13.1K ﹤0.01% 5597
2018
Q2 		$12K Sell
25
-10
-29% -$5.29K ﹤0.01% 5758
2018
Q1 		$21K Buy
35
+10
+40% +$6.2K ﹤0.01% 5426
2017
Q4 		$14K Sell
25
-100
-80% -$45.3K ﹤0.01% 5729
2017
Q3 		$52K Buy
125
+100
+400% +$30.6K ﹤0.01% 5383
2017
Q2 		$6K Hold
25
– – ﹤0.01% 5969
2017
Q1 		$8K Buy
+25
New +$6.13K ﹤0.01% 6053
2015
Q4 		– Sell
-48
Closed -$5K – 6616
2015
Q3 		$5K Sell
48
-18
-27% -$3.17K ﹤0.01% 6150
2015
Q2 		$15K Buy
+66
New +$12.7K ﹤0.01% 5848
2013
Q3 		– Sell
-3
Closed – – 6072
2013
Q2 		$0 Buy
+3
New +$470 ﹤0.01% 5818

Other funds holding ASMB

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Royal Bank of Canada's ASMB Position: Q1 2026 in Review

Royal Bank of Canada opened a new position in Assembly Biosciences (ASMB) in Q1 2026: 16 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #7086 among its holdings. This is a return to the name: Royal Bank of Canada previously reported a position in ASMB as recently as Q2 2025.

Royal Bank of Canada first reported a position in ASMB in Q2 2013 and has held it in 28 quarters since. The position peaked at $52K in Q3 2017. 75 funds tracked by Wall St. Rank hold ASMB as of Q1 2026.

  • Royal Bank of Canada held 16 shares of Assembly Biosciences worth $0 as of Q1 2026.
  • Assembly Biosciences was a new Royal Bank of Canada position in Q1 2026.
  • Assembly Biosciences made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #7086 holding.
  • Royal Bank of Canada first reported a position in Assembly Biosciences in Q2 2013 and has held it in 28 quarters since.
  • Royal Bank of Canada's Assembly Biosciences position peaked at $52K in Q3 2017.
  • 75 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.